HER2 Support Group Forums - View Single Post - Geron commences GRN1005 Phase 2 trial in breast cancer

News · 12-12-2011, 11:30 PM

Geron Corporation today announced the initiation of GRABM-B (GRN1005 Against Brain Metastases - Breast cancer), a Phase 2 clinical trial to evaluate GRN1005 in patients with brain metastases arising from breast cancer.

More...

12-12-2011, 11:30 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,723	Geron commences GRN1005 Phase 2 trial in breast cancer Geron Corporation today announced the initiation of GRABM-B (GRN1005 Against Brain Metastases - Breast cancer), a Phase 2 clinical trial to evaluate GRN1005 in patients with brain metastases arising from breast cancer. More...